
Isavuconazole 7 - (S, R)-2,5-difluorophenyl Hydroxy Methyl 1h-1,2,4-triazole-1-butanenitrile Powder, Medicine Grade 99% Purity
Get Latest Price
Minimum Order Quantity :
1g
In Stock
Product Specifications
| Usage | Isavuconazole has been approved by the FDA for treatment of invasive aspergillosis and invasive mucormycosis in adults ages 18 years and older. Both infections are caused by mold and fungi common to the environment, and occur in individuals who are immunosuppressed or have other complicating conditions, such as diabetes or lung disease. |
| Type | Other |
| Molecular Weight | 278.2573864 Grams (g) |
| Form | Powder |
| Application | Pharmaceutical Industry |
| Appearance | white powder |
| CAS No | 241479-74-3 |
| Other Names | (I S,I R)-I -(2,5-Difluorophenyl)-I -hydroxy-I -Methyl-1H-1,2,4-triazole-1-butanenitrile |
| Place of Origin | China |
| Purity | 99%min |
| Molecular Formula | C13H12F2N4O |
| Grade | Medicine Grade |
| Packaging Details | foil/bag/bottle |
| Delivery Time | ship immediately after confirmation if there have material in stock Days |
| Sample Available | 1 |
| Supply Ability | 500kg Per Day |
| Payment Terms | Telegraphic Transfer (T/T) |
| Main Export Market(s) | Middle East |
| Sample Policy | Contact us for information regarding our sample policy |
| FOB Port | Shanghai |
| GSTIN | 0% |
Product Overview
Key Features
Company Details
Focusing on a customer-centric approach, CHEMVON BIOTECHNOLOGY (SHANGHAI) CO. LTD. has a pan-India presence and caters to a huge consumer base throughout the country. Buy Chemical Supplies in bulk from CHEMVON BIOTECHNOLOGY (SHANGHAI) CO. LTD. at Trade India quality-assured products.
Business Type
Exporter, Manufacturer, Distributor, Supplier, Trading Company
Employee Count
250
Establishment
2004
Working Days
Monday To Sunday
Related Products
Explore Related Categories
More Products From This Seller
Seller Details
Shanghai, Shanghai
CEO
Mr. Peter Dong Wang
Address
Suite B-10, Chuansha Road 6999#, Shanghai, Shanghai, 201203, China
chemical compound in Shanghai
Report incorrect details










































